Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
about
Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinEpigenetic associations in relation to cardiovascular prevention and therapeuticsAntioxidants in Cardiovascular Therapy: Panacea or False Hope?Antioxidants, inflammation and cardiovascular diseaseCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesHyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males.Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant systemEffect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot studySerum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate/product ratios.Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population.The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.Role of folic acid in nitric oxide bioavailability and vascular endothelial function.Homocysteine, frailty, and all-cause mortality in older men: the health in men study.DNA Methylation and the Potential Role of Methyl-Containing Nutrients in Cardiovascular Diseases.
P2860
Q26750865-0FE02BB3-E294-49D2-BA64-0A6B88190282Q26771428-0C5A8875-2404-4291-90A7-A9929C3A0018Q26776115-27EDF1AF-56F4-4D37-92E4-4F461FA8C122Q26823009-B1AB0DE1-87C7-4408-B3C6-C33809BB82DBQ27002459-D8756D2B-9EAF-4718-B4C7-210BF86D4F64Q33883346-A8FCFCBA-F217-4BEB-9A03-E6F7B3E91475Q35885268-4C974308-44FA-4F07-AD9E-2E989F7539E5Q36547780-C6E85E6D-7A92-4AC9-8BB7-803F5A7BC2A8Q36798688-A90187F7-AF28-42C7-810E-039D06F6B67FQ36922230-0DD42771-138D-4282-9C25-B7C8A1BEB8A5Q38191275-18688D26-9650-49B1-A720-42CA09864E3DQ39038629-66AD3F6B-DB9F-4FD0-868E-030C9F05BB25Q43780318-E751084F-8615-43C3-A516-68AAB8890527Q48214417-F5DDE3B4-2641-48B7-9687-E906415D1A89
P2860
Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@en
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@nl
type
label
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@en
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@nl
prefLabel
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@en
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@nl
P2860
P921
P1476
Why do homocysteine-lowering B ...... on of cardiovascular diseases?
@en
P2093
Balazs Debreceni
Laszlo Debreceni
P2860
P304
P356
10.1111/J.1755-5922.2011.00266.X
P577
2011-04-01T00:00:00Z